Tune Therapeutics receives approval to initiate clinical trial in Hong Kong ...
The company’s leading therapeutic candidate, Tune-401, has now been approved for clinical trials in both Hong Kong and New Zealand. Leading epigenetic therapy company Tune Therapeutics will begin a clinical trial in Ho...